INSM insiders

15 insiders have filed at INSM since 2023Q3: names, roles, reported stakes, and each person's buying and selling record from SEC Form 3/4/5 filings.

namerolereported stake% of companybuys (3y)sells (3y)
Lewis WilliamChair And CEO535.1k0.248%150 sells $68.7M
Sharoky Melvin MdDirector269.6k0.125%4 sells $8.1M
Wise John DraytonChief Commercial Officer133.0k0.062%12 sells $2.7M
Brennan David RDirector120.9k0.056%
Adsett RogerChief Operating Officer106.8k0.05%27 sells $14.5M
Mcgirr David W JDirector97.7k0.045%2 sells $452k
Flammer Martina M.D.Chief Medical Officer83.2k0.039%69 sells $77.5M
Bonstein SaraChief Financial Officer79.8k0.037%32 sells $42.8M
Desjardins ClarissaDirector70.0k0.033%2 buys $202k
Altomari AlfredDirector69.5k0.032%
Schafer CarolDirector63.3k0.029%
Anderson Elizabeth MDirector58.7k0.027%2 sells $3.0M
Lee LeoDirector54.7k0.025%5 sells $14.7M
Smith Michael AlexanderChief Legal Officer51.9k0.024%43 sells $31.4M
Schaeffer Orlov S NicoleChief People Strategy Officer41.8k0.019%42 sells $65.3M

Full register at boothcheck.com/insiders/INSM. Stakes are the newest reported Form 3/4/5 balances (they update only when insiders file). Sales counted include pre-scheduled plan sales, labeled. A filed record, not a forecast. Nothing here is investment advice.

INSM institutional holders · INSM research report